Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis

Rationale: Although mesenchymal stem cell (MSC) transplantation has been proved to be an effective therapeutic approach to treat experimental Sjögren's syndrome (SS), the detailed underlying mechanisms remains unknown. IL-27 has diverse influences on the regulation of T cell differentiation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Genhong, Qi, Jingjing, Liang, Jun, Shi, Bingyu, Chen, Weiwei, Li, Wenchao, Tang, Xiaojun, Wang, Dandan, Lu, Liwei, Chen, Wanjun, Shi, Songtao, Hou, Yayi, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857067/
https://www.ncbi.nlm.nih.gov/pubmed/31754394
http://dx.doi.org/10.7150/thno.37351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857067/
https://www.ncbi.nlm.nih.gov/pubmed/31754394
http://dx.doi.org/10.7150/thno.37351

Ejemplares similares